Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Clayman

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Head & Neck|July 1, 1996
Early squamous cell carcinoma of the hypopharynx: outcomes of treatment with radiation alone to the primary diseaseA S Garden, W H Morrison, G L Clayman, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 1, 1994
Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survivalG L Clayman, M G Stewart, R S Weber, et al.
The Laryngoscope|September 25, 2001
All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinomaT Nakashima, S Y Sun, R Lotan, et al.
The Annals of Otology, Rhinology, and Laryngology|November 1, 1992
Detection of regulatory factors of lymphokine-activated killer cell activity in head and neck cancer patients treated with interleukin-2 and interferon alphaG L Clayman, G Young, D L Taylor, et al.
The Laryngoscope|January 1, 1993
Serologic determinants of survival in patients with head and neck cancer: validating a clinical prediction modelD D Lydiatt, H E Savage, G L Clayman, et al.
The Laryngoscope|March 1, 1993
Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cellsG L Clayman, D L Taylor, F J Liu, et al.
The American Journal of Pathology|June 1, 1996
Microsatellite instability in preinvasive and invasive head and neck squamous carcinomaA K El-Naggar, K Hurr, V Huff, et al.
Biochimica Et Biophysica Acta|September 27, 2000
Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cellsT Nakashima, S C Pak, G A Silverman, et al.
Cancer Research|July 15, 1994
Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirusT J Liu, W W Zhang, D L Taylor, et al.
Archives of Otolaryngology--Head & Neck Surgery|May 1, 1996
Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21)G L Clayman, T J Liu, S M Overholt, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Head & Neck|July 1, 1996
Early squamous cell carcinoma of the hypopharynx: outcomes of treatment with radiation alone to the primary diseaseA S Garden, W H Morrison, G L Clayman, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 1, 1994
Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survivalG L Clayman, M G Stewart, R S Weber, et al.
The Laryngoscope|September 25, 2001
All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinomaT Nakashima, S Y Sun, R Lotan, et al.
The Annals of Otology, Rhinology, and Laryngology|November 1, 1992
Detection of regulatory factors of lymphokine-activated killer cell activity in head and neck cancer patients treated with interleukin-2 and interferon alphaG L Clayman, G Young, D L Taylor, et al.
The Laryngoscope|January 1, 1993
Serologic determinants of survival in patients with head and neck cancer: validating a clinical prediction modelD D Lydiatt, H E Savage, G L Clayman, et al.
The Laryngoscope|March 1, 1993
Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cellsG L Clayman, D L Taylor, F J Liu, et al.
The American Journal of Pathology|June 1, 1996
Microsatellite instability in preinvasive and invasive head and neck squamous carcinomaA K El-Naggar, K Hurr, V Huff, et al.
Biochimica Et Biophysica Acta|September 27, 2000
Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cellsT Nakashima, S C Pak, G A Silverman, et al.
Cancer Research|July 15, 1994
Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirusT J Liu, W W Zhang, D L Taylor, et al.
Archives of Otolaryngology--Head & Neck Surgery|May 1, 1996
Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21)G L Clayman, T J Liu, S M Overholt, et al.
Pageof 10